Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 11.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008

Recipients with Heart Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 919 100.0% 8,954 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 73 7.9% 482 5.4%
OKT3 11 1.2% 226 2.5%
Thymoglobulin 249 27.1% 1,444 16.1%
Zenapax 59 6.4% 1,299 14.5%
Simulect 45 4.9% 1,288 14.4%
Campath 164 17.8% 35 0.4%
Rituximab 2 0.2% 37 0.4%
No Induction Drug Reported 329 35.8% 4,438 49.6%


Source: OPTN/SRTR Data as of May 4, 2009.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader